Sub-study of the Essen Study Centre for the ENTAiER Trial

NCT04532073 | Completed

• 1 other identifier: 20-9421-BO
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The present study is a sub-study of the ENTAiER study. The ENTAiER study is a multicenter, randomized, controlled study to evaluate the efficacy and safety of eurythmy therapy and Tai Chi in comparison to standard care in chronically ill older patients with an increased risk of falling. In addition to the main questions of the ENTAiER study, three additional questions are being investigated at the Hospital Essen-Steele: Proteome and telomere analyses as well as qualitative parameters are recorded and examined. The aim is to compare the changes in proteomes, telomeres and qualitative factors under eurythmy therapy, Tai Chi and standard care in chronically ill older patients with an increased risk of falling.

Conditions

Elderly Patients; Chronically Ill; Increased Risk of Falling

Outcome Measures

Primary Outcomes (3)

• Change in proteomic analysis from baseline to after intervention

  A maximum of 500 µL plasma is used for the proteomic studies. The proteins are digested tryptically, a concentration determination is performed by amino acid analysis and the peptide samples are then measured by different mass spectrometric methods (data dependent (DDA) and independent detection (DIA), proteome-wide prediction of peptide tandem mass spectra by deep learning (Prosit), etc.). The results obtained are then verified by Western blot, ELISA and/or a targeted mass spectrometric method (parallel reaction monitoring)

  Before intervention (week 0) and after intervention (6 months)

• Change in telomer analysis from baseline to after intervention

  The telomere length is determined from blood samples using quantitative real-time PCR (TaqMan) from genomic DNA.

  Before intervention (week 0) and after intervention (6 months)

• Qualitative parameter

  By means of semi-structured interviews of maximum 60 minutes per participant, the effects of the intervention are to be recorded qualitatively.

  After intervention (6 months)

Study Arms (3)

Eurythmy therapy exercises

EXPERIMENTAL

As part of the ENTAiER trial: In group sessions á 5 patients with a qualified therapist: In the first 3 months twice a week, in the second 3 months once a week. Recommendation to practice at home on at least 3 days per week (optimal, practice daily). They are supported by an eurythmy manual and an exercise video. This supplements the regular care.

Other: Eurythmy Therapy

Tai Chi exercises

EXPERIMENTAL

As part of the ENTAiER trial:In group sessions of 5 patients each with a qualified teacher: In the first 3 months twice a week, in the second 3 months once a week. Recommendation to practice at home on at least 3 days per week (optimal, practice daily). They are supported by a Tai Chi Manual and an exercise video. This complements the regular care

Other: Tai Chi

Standard Care Only

ACTIVE COMPARATOR

As part of the ENTAiER trial:Brochure with detailed description of various evidence-based measures for fall prevention, prepared for the specific age group (https://www.trittsicher.org/files/trittsicher\_bzga\_sturzpraevention\_2015-11-23.pdf) \- Recommendation to visit the family doctor and discuss fall prophylaxis with her

Other: Standard Care

Interventions

Eurythmy Therapy OTHER

A mindfulness-oriented movement therapy

Eurythmy therapy exercises

Tai Chi OTHER

A martial art developed in China, which in recent times is often regarded as a system of movement theory or gymnastics

Tai Chi exercises

Standard Care OTHER

Treatment process that a clinician should follow for a certain type of patient

Standard Care Only

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• At least 65 years.
• Chronic disease (musculoskeletal, neurological, internal medicine).
• Increased risk of falling (Berg Balance Scale Score 49 or less).
• Medical history: feeling of balance disturbance in the past.
• Independent living at home or in an old people's or retirement home.
• Regular participation in a one-hour event is possible.
• Sufficiently mobile to leave the place of residence independently at least twice a week
• Written declaration of consent.

You may not qualify if:

• Disease that restricts participation (e.g. terminal disease, heart failure NYHA III-IV, unstable angina pectoris, uncontrolled seizure disorder, decompensated lung disease that already leads to shortness of breath during light activity, advanced cancer, chemo- or radiotherapy ongoing or during the last 3 months, amputation of one or both legs)
• Complete dependence on the rollator.
• Visual, hearing or speech problems that limit the understanding of the study documents and processes.
• Major cognitive impairment (MoCA score 18 or less).
• High risk of needing individual supervision during group sessions.
• Severe personality disorder or psychiatric illness, alcoholism or other substance dependence affecting the group sessions.
• Life expectancy under 1 year.
• Permanent bed-riddenness expected in less than one year.
• Regular participation in Tai Chi or EYT in the last 6 months.
• Participation in intensive sports activities in the last month (e.g. training in the fitness centre or in sports groups which lead to breathlessness and sweating; skiing, mountaineering in high mountains).
• Patients who cannot understand the nature, meaning and necessities of participating in a study.
• Participation in another clinical trial within 3 months prior to screening for the ENTAiER trial or concurrent participation in another trial that may interfere with this trial.

Sponsors & Collaborators

• Universität Duisburg-Essen: lead
• Software AG Stiftung: collaborator
• Universität Freiburg: collaborator

Study Sites (1)

Kliniken Essen-Mitte

Essen, 45276, Germany

Location

Related Links

• Main study

MeSH Terms

Conditions

Chronic Disease

Interventions

Tai Ji; Standard of Care

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body Therapies; Complementary Therapies; Therapeutics; Exercise Movement Techniques; Physical Therapy Modalities; Quality Indicators, Health Care; Quality of Health Care; Health Services Administration; Health Care Quality, Access, and Evaluation

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Director

Study Record Dates

• First Submitted: August 20, 2020
• First Posted: August 31, 2020
• Study Start: July 27, 2021
• Primary Completion: December 7, 2022
• Study Completion: December 7, 2022
• Last Updated: December 21, 2023

Record last verified: 2023-12

Data Sharing

• IPD Sharing: Will not share

Locations

DE (1)